Dianwen Ju

13.6k total citations
146 papers, 4.0k citations indexed

About

Dianwen Ju is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Dianwen Ju has authored 146 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 51 papers in Immunology and 45 papers in Epidemiology. Recurrent topics in Dianwen Ju's work include Autophagy in Disease and Therapy (32 papers), CAR-T cell therapy research (19 papers) and Phagocytosis and Immune Regulation (15 papers). Dianwen Ju is often cited by papers focused on Autophagy in Disease and Therapy (32 papers), CAR-T cell therapy research (19 papers) and Phagocytosis and Immune Regulation (15 papers). Dianwen Ju collaborates with scholars based in China, United States and South Korea. Dianwen Ju's co-authors include Jiajun Fan, Xian Zeng, Yubin Li, Jingyun Luan, Xuyao Zhang, Wei Chen, Shaofei Wang, Yichen Wang, Yun Sun and Ping Song and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dianwen Ju

136 papers receiving 4.0k citations

Peers

Countries citing papers authored by Dianwen Ju

Since Specialization

Citations

This map shows the geographic impact of Dianwen Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianwen Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianwen Ju more than expected).

Fields of papers citing papers by Dianwen Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianwen Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianwen Ju. The network helps show where Dianwen Ju may publish in the future.

Co-authorship network of co-authors of Dianwen Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Dianwen Ju. A scholar is included among the top collaborators of Dianwen Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianwen Ju. Dianwen Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy 2025 ·International Journal of Biological Macromolecules ·(unknown), Shuai Li, Kia Joo Puan, Xueting Li, Caili Xu, Jiajun Fan, Zhen Dou, Jiquan Zhang, Dianwen Ju	0
2	A Hyperbolic Discrete Diffusion 3D RNA Inverse Folding Model for Functional RNA Design 2025 ·Journal of Chemical Information and Modeling ·(unknown), Shuai Zhang, (unknown), Hung‐Yun Lin, Zheng Wan, Huijun Zhao, (unknown), Xiao He, (unknown), Dianwen Ju, Xian Zeng	0
3	Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era 2024 ·Biomedicines ·(unknown), Dianwen Ju, Xian Zeng	26
4	A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE 2024 ·Cell Death and Disease ·Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lü, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang	9
5	Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles 2023 ·Biomaterials ·(unknown), (unknown), (unknown), Xianxian Yao, Dianwen Ju, Xian Zeng, Zhiqing Pang, Wuli Yang	28
6	Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response 2023 ·Cell Death Discovery ·Zhonglian Cao, Hui Zhao, Jiajun Fan, Yilan Shen, Lei Han, Guangjun Jing, Xian Zeng, Xin Jin, (unknown), Qi Bian, Yanyang Nan, (unknown), Xiaobin Mei, Dianwen Ju, Ping Yang	16
7	CMAUP database update 2024: extended functional and association information of useful plants for biomedical research 2023 ·Nucleic Acids Research ·(unknown), (unknown), (unknown), (unknown), Xingxiu Li, Yuan Yang, (unknown), (unknown), Jiayu Wang, Hui Zhao, Xuyao Zhang, Jiajun Fan, (unknown), Dan Wang, (unknown), Dianwen Ju, Yu Chen, Xian Zeng	11
8	Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus 2023 ·Biomedicines ·Chenchen Shi, Chang Su, (unknown), Lei Han, (unknown), (unknown), Xunlong Shi, Dianwen Ju, Yiou Cao, Haiyan Zhu	4
9	Innate Immunity in Cancer Biology and Therapy 2023 ·International Journal of Molecular Sciences ·Yuxia Zhang, Wenjing Xue, Caili Xu, Yanyang Nan, Shuang Mei, Dianwen Ju, Shaofei Wang, Xuyao Zhang	11
10	A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation 2023 ·Applied Microbiology and Biotechnology ·Yilan Shen, Yuqing Xu, Pei Kang Shen, (unknown), Qi Bian, Lei Han, Zhonglian Cao, Jiajun Fan, Xian Zeng, Yuting Zhang, Zhiyong Guo, Dianwen Ju, Xiaobin Mei	4
11	Targeting CD47 Enhanced the Antitumor Immunity of PD-L1 Blockade in B-Cell Lymphoma 2023 ·Immunotherapy ·Yanyang Nan, Xuyao Zhang, Shaofei Wang, Caili Xu, Yichen Wang, Lei Han, Jingyun Luan, (unknown), Wei Chen, Zhonglian Cao, (unknown), Xian Zeng, Jiajun Fan, Li Ye, Xunlong Shi, Dianwen Ju	3
12	An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases 2020 ·Frontiers in Immunology ·Peipei Liu, Zhongzong Pan, Chunyin Gu, Xiaodan Cao, (unknown), Jianjian Zhang, (unknown), Xueping Wang, (unknown), Dianwen Ju, Su-Jun Deng	11
13	Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer 2019 ·Journal for ImmunoTherapy of Cancer ·Xuyao Zhang, Yichen Wang, Jiajun Fan, Wei Chen, Jingyun Luan, Xiaobin Mei, Shaofei Wang, Yubin Li, Li Ye, Song Li, Wenzhi Tian, Kai Yin, Dianwen Ju	82
14	Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer 2017 ·Cancer Immunology Research ·Xuyao Zhang, Jiajun Fan, Shaofei Wang, Yubin Li, Yichen Wang, Li Song, Jingyun Luan, Ziyu Wang, Ping Song, Qicheng Chen, Wenzhi Tian, Dianwen Ju	89
15	Deprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma 2017 ·Applied Microbiology and Biotechnology ·(unknown), Li Li, (unknown), Xuyao Zhang, Jingyun Luan, Shuwei Zhao, Huanhai Liu, Dianwen Ju	23
16	Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells 2014 ·Applied Microbiology and Biotechnology ·Jiajun Fan, Xiaochun Dong, Weixing Zhang, Xian Zeng, Yubin Li, Yun Sun, Shaofei Wang, (unknown), Hongjian Gao, Weili Zhao, Dianwen Ju	5
17	The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers 2014 ·Biomaterials ·Shaofei Wang, Yubin Li, Jiajun Fan, Ziyu Wang, Xian Zeng, Yun Sun, Ping Song, Dianwen Ju	79
18	PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice 2013 ·Applied Microbiology and Biotechnology ·Xunlong Shi, Zhihui Shi, Hai Huang, Hongguang Zhu, Haiyan Zhu, Dianwen Ju, Pei Zhou	19
19	Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity 2002 ·Cancer Gene Therapy ·Linhui Wang, (unknown), Yinghao Sun, Liang Li, Dianwen Ju	15
20	Effects of granulocyte-macrophage colony stimulating factor gene encoded vaccinia virus vector on murine pulmonary metastatic melanoma 1997 ·Chinese Journal of Cancer Research ·Dianwen Ju, Xuetao Cao, Tao Wan, (unknown), Baomei Wang, Yizhi Yu, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact